Early Mepolizumab to Induce EGPA Remission May Pay Off
Summary
Mepolizumab treatment in early EGPA may not beat conventional therapy in inducing remission, but its use may pay off later at 1 year and lead to reduced steroid use.
Description from Medscape.
Who is covering this
-
Early Mepolizumab to Induce EGPA Remission May Pay Off
Mepolizumab treatment in early EGPA may not beat conventional therapy in inducing remission, but its use may pay off later at 1 year and lead to reduced steroid use.
Comments
Comments need JavaScript.